Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLGW) Change in Cash (2016 - 2017)

Bone Biologics (BBLGW) has disclosed Change in Cash for 2 consecutive years, with -$931700.0 as the latest value for Q4 2017.

  • Quarterly Change in Cash fell 1273.01% to -$931700.0 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $69904.0 through Dec 2017, up 114.13% year-over-year, with the annual reading at $2.0 million for FY2025, 572.96% up from the prior year.
  • Change in Cash for Q4 2017 was -$931700.0 at Bone Biologics, down from $838965.0 in the prior quarter.
  • The five-year high for Change in Cash was $3.1 million in Q1 2016, with the low at -$2.0 million in Q2 2016.